About us

The technology behind Oxaphil

In many industries and in everyday life, we are constantly surrounded by products made of plastics/polymers. One special application for polymers is the solubilization of water-insoluble substances such as vegetable oils or active pharmaceutical ingredients in an aqueous environment. This is achieved using special polymers such as polyethylene glycol (PEG) and its derivatives, which dominate the solubilizer market.

However, current studies show that contact with PEG leads to the formation of antibodies against PEG in a large number of people. This is problematic as it drastically limits the usability of PEG. This is where we come in: As an alternative to PEG, we offer poly(2-oxazoline)s (POx), which not only avoid the current problems of PEG, but also have superior properties to PEG, such as biocompatibility, more chemically usable groups or better solvent properties.

POx are a class of substances that are well-researched, but can only be produced in the laboratory by specialists. In particular, the repeated production of consistent quality and industrial quantities has not been feasible in the past. Oxaphil has changed this: with our processes, POx are available in large quantities for the first time. Contact us!

The people behind Oxaphil

Behind every technological solution are decisions, experience, and people who know what they’re doing. At Oxaphil, we combine scientific excellence with the determination to make novel materials not just conceivable, but applicable. Our team brings together diverse perspectives from research, application, and development with a clear focus on quality, scalability, and impact.

We believe that technology is never accidental. It is the result of expertise, conviction, and shared responsibility.